Leading the fight against multiple sclerosis

A team of researchers have discovered the first biomarker – a chemical identified in the blood – enabling a simple blood test to rapidly and accurately determine, with 85 to 95 per cent accuracy, which type of multiple sclerosis a patient has.

Find out more

View our Research collaboration and partnership page for more information on research partnerships.

Back to the top of this page